Concepts (229)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Acute Lung Injury
- Administration, Intravenous
- Adolescent
- Adrenal Cortex Hormones
- Adult
- Aftercare
- Age Factors
- Aged
- Aged, 80 and over
- Algorithms
- Analysis of Variance
- Anemia
- Anemia, Sickle Cell
- Angioplasty, Balloon
- Animals
- Annexin A5
- Anorexia Nervosa
- Antibodies, Antinuclear
- Antibodies, Antiphospholipid
- Anticoagulants
- Antifibrinolytic Agents
- Anti-Inflammatory Agents
- Antiphospholipid Syndrome
- Antirheumatic Agents
- Antiviral Agents
- Aprotinin
- Atrial Fibrillation
- beta 2-Glycoprotein I
- Betacoronavirus
- Biomarkers
- Blood Chemical Analysis
- Blood Coagulation
- Blood Coagulation Disorders
- Blood Coagulation Factors
- Blood Coagulation Tests
- Blood Component Transfusion
- Blood Loss, Surgical
- Blood Transfusion
- Blood Transfusion, Autologous
- Body Mass Index
- Brain
- Breast Neoplasms
- Calibration
- Cardiac Surgical Procedures
- Cardiopulmonary Bypass
- Case-Control Studies
- Catheterization, Peripheral
- Catheters, Indwelling
- Chemoprevention
- Child
- Child, Preschool
- Chromatography, High Pressure Liquid
- Clinical Decision-Making
- Clinical Laboratory Techniques
- Clinical Trials as Topic
- Cohort Studies
- Complement C3a
- Complement System Proteins
- Computed Tomography Angiography
- Coronavirus Infections
- C-Reactive Protein
- Critical Care
- Critical Illness
- Dalteparin
- Delivery of Health Care
- Diagnosis, Differential
- Diagnostic Techniques, Cardiovascular
- Disease Management
- Disseminated Intravascular Coagulation
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Drug Recalls
- Early Detection of Cancer
- Early Termination of Clinical Trials
- Ebolavirus
- Emergency Service, Hospital
- Endovascular Procedures
- England
- Enzyme Inhibitors
- Erythrocytes
- Europe
- Extracorporeal Membrane Oxygenation
- Factor V
- Factor Xa
- Factor Xa Inhibitors
- Female
- Fibrin Fibrinogen Degradation Products
- Fibrinogen
- Fibrinolysis
- Fibrinolytic Agents
- Glycosaminoglycans
- Government Programs
- Health Personnel
- Heart Defects, Congenital
- Hemoglobins
- Hemolytic-Uremic Syndrome
- Hemorrhage
- Hemorrhagic Fever, Crimean
- Hemorrhagic Fever, Ebola
- Hemostasis
- Hemostasis, Surgical
- Heparin
- Heparin, Low-Molecular-Weight
- Hospital Mortality
- Hospitalization
- Hospitals
- Humans
- Hydrocortisone
- Hydroxychloroquine
- Hydroxyethyl Starch Derivatives
- Iliac Vein
- Immunoglobulin G
- Immunologic Factors
- Incidence
| - Infant
- Infant, Newborn
- Inflammation
- Influenza A virus
- Influenza A Virus, H1N1 Subtype
- Influenza B virus
- Influenza, Human
- Inpatients
- Intensive Care Units
- International Normalized Ratio
- Intracranial Hemorrhages
- Length of Stay
- Limit of Detection
- Logistic Models
- London
- Lung Neoplasms
- Male
- Mass Screening
- Mediastinum
- Medical Audit
- Middle Aged
- Models, Statistical
- Mortality
- Neoplasms
- Neoplasms, Unknown Primary
- Neovascularization, Physiologic
- Nigeria
- Obesity
- Odds Ratio
- Operative Blood Salvage
- Organ Transplantation
- Oxygen
- Pandemics
- Paresis
- Partial Pressure
- Perioperative Care
- Plasma
- Plasma Substitutes
- Platelet Aggregation Inhibitors
- Pneumonia, Viral
- Point-of-Care Testing
- Postoperative Hemorrhage
- Postpartum Hemorrhage
- Postthrombotic Syndrome
- Practice Guidelines as Topic
- Predictive Value of Tests
- Pregnancy
- Pregnancy Complications
- Pregnancy Complications, Cardiovascular
- Pregnancy Complications, Infectious
- Pregnancy Outcome
- Prevalence
- Prognosis
- Prospective Studies
- Prostate-Specific Antigen
- Prostatic Neoplasms
- Prothrombin
- Prothrombin Time
- Pulmonary Edema
- Pulmonary Embolism
- Purpura, Thrombocytopenic, Idiopathic
- Randomized Controlled Trials as Topic
- Recombinant Proteins
- Recurrence
- Research Design
- Respiration, Artificial
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Rivaroxaban
- Sensitivity and Specificity
- Severity of Illness Index
- Shock
- Sierra Leone
- Spain
- State Medicine
- Stents
- Survival Analysis
- Tandem Mass Spectrometry
- Tertiary Care Centers
- Tertiary Healthcare
- Thrombelastography
- Thrombin
- Thrombocytopenia
- Thromboembolism
- Thrombophilia
- Thromboplastin
- Thrombosis
- Thrombotic Microangiopathies
- Time Factors
- Tissue and Organ Procurement
- Tissue Donors
- Tomography, X-Ray Computed
- Tranexamic Acid
- Treatment Failure
- Treatment Outcome
- Turkey
- Ultrasonography, Doppler
- Uncertainty
- United Kingdom
- United States
- Vaccines
- Vascular Endothelial Growth Factor A
- Vascular Patency
- Veins
- Venous Thromboembolism
- Venous Thrombosis
- Ventilation-Perfusion Ratio
- Vitamin K
- Warfarin
- Women's Health
- World Health Organization
- Wounds and Injuries
- Young Adult
|
Hunt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(229)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1409)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_